CIMIC Group companies Pacific Partnerships, UGL and CPB Contractors, as part of the Momentum Trains consortium, have been selected by Transport for NSW to deliver the $1.26 billion Regional Rail Project as a design, build, finance and maintain contract. The… Read More ›
Australia
DomaCom (ASX: DCL) – Valuable fractions of a huge pie
Article written by Pitt Street Research. For the full report click here Revolutionary property investment platform We believe today’s property investing in Australia is archaic and ripe for disruption. Property investors can essentially only acquire entire properties, e.g. in their SMSF,… Read More ›
Greenland Minerals (ASX: GGG) – Continuous improvement
Article written by Pitt Street Research. For the full report click here Kvanefjeld’s cost position improves regularly Greenland Minerals’ Kvanefjeld Rare Earths Project in Greenland covers the world’s largest undeveloped Rare Earths deposit. A notable aspect of the Kvanefjeld story has… Read More ›
Nanosonics Shares (ASX: NAN) – Is It A Stock To Buy?
This article was originally published at MF & Co. Asset Management. Nanosonics (ASX NAN) has a clear and reliable strategy for future development and a revolutionary monopolistic product (Trophon 2). The company also just achieved regulatory approvals in key markets and… Read More ›
BlackWall (ASX:BWF) – A High-Growth Property Play
Article written by Pitt Street Research. For the full report click here Attractive yields in property management BlackWall Limited (ASX:BWF) is a Sydney-based property company with a long track record in development and funds management. The group is also growing a… Read More ›
ParaZero Limited (ASX: PRZ) – PRZ enters consumer market
Article written by Pitt Street Research. For the full report click here SafeAir for the world’s most popular drone With the launch of its latest autonomous drone safety system, the ‘SafeAir Phantom’, Parazero Limited (ASX:PRZ) expands into the high-volume, consumer-oriented drone… Read More ›
The Red Flags of High-Risk Properties
When it comes to buying property, the current climate means it is very much a case of buyer beware. RiskWise Property Research CEO Doron Peleg said the second half of 2018 saw the major risks associated with the residential property… Read More ›
Why Rural Funds Group Shares (ASX: RFF) Is A Good Buy
This article was originally published at MF & Co. Asset Management. Rural Funds Group shares (ASX RFF) is the only diversified agricultural Real Estate Investment Trust (REIT) in Australia which controls more than 40 properties across sectors including almond, cattle,… Read More ›
Crypto-Lending Business Helio Lending Launches Regulated Investment Fund
Crypto-lending business launches regulated investment fund Australian-based, government-regulated cryptocurrency lender, Helio Lending today confidently launched a new arm of its business, the Helio Secured Income Fund — a regulated Managed Investment Scheme with an Australian Financial Services Licence — investors are now… Read More ›
Five-Year Analysis of Property Market Shows High Rental Yields Do Not Mean High Returns
A five-year analysis of the property market has shown high rental yields do not necessarily mean high overall returns for investors. In fact, the latest astounding analysis by independent research house RiskWise Property Research has proven that over the medium… Read More ›
CIMIC’s (ASX: CIM) Sedgman wins $155m coal contract in Queensland
CIMIC Group’s mineral processing company, Sedgman, has been awarded a contract at the Byerwen Coal Mine in Central Queensland, continuing CIMIC Group’s long standing relationship with QCoal Group. The engineering, procurement and construction (EPC) contract will deliver an expansion… Read More ›
Dwelling commencement – the risk to Australia’s GDP
While property experts are forecasting strong reductions in residential dwelling commencements, the figures are likely to be much higher and the impact will be significant on both the broader economy and, particularly, GDP growth. This is the message from RiskWise… Read More ›
National Cyber Security Adviser urges end to complacency after global theft of commercial secrets
The Australian Cyber Security Centre (ACSC) is providing assistance to ICT managed service providers (MSPs) in the wake of the global cyber security compromise confirmed by the Australian Government. Alastair MacGibbon, Head of the ACSC and National Cyber Security Adviser,… Read More ›
EML Payments (ASX: EML) – Powers Australian Fintech
EML Payments today announces the launch of new payments programs for four of Australia’s most innovative Fintechs: WildCard, Qpay, DiviPay, and ImpactPay. Tom Cregan, CEO EML Payments, says it’s EML’s product innovation, processing technology and Mastercard issuing licence that’s placed… Read More ›
Is The S&P500 (SPX) Oversold?
This article was originally published at MF & Co. Asset Management. With the recent volatility in the markets and a major correction underway since the start of October, the end of the correction doesn’t look to be anywhere close to… Read More ›
MinterEllison’s Directions in Capital Markets 2018 and Predictions 2019
It has been a year of ups and downs for both ECM and DCM in Australia according to the fourth edition of MinterEllison’s Directions in Capital Markets 2018 report. The report identifies six key ECM trends and two key DCM trends… Read More ›
PainChek (ASX:PCK) – Smart Opportunity In Pain Relief
Article written by Pitt Street Research. For the full report click here Setting global benchmark in pain assessment PainChek is a Sydney-based pain assessment tool provider. Considering lack of any global benchmark in pain assessment, PainChek is expected to set a… Read More ›
EXCLUSIVE: Interview with Comvita (NZE: CVT) Management (Part 1)
We were lucky to have the chance to interview the top management team of one of the hottest NZ listed companies: Comvita. As reported on Comvita website, they “are an international natural health products company backed by a strong New… Read More ›
Neuren Pharmaceuticals (ASX: NEU) – In Phase 3, priced like Phase 2
Article written by Pitt Street Research. For the full report click here The Neuren/Acadia deal has been misunderstood When Neuren Pharmaceuticals, a drug development company focused on neurology drugs, partnered its lead molecule, called Trofinetide, to Acadia Pharmaceuticals in August 2018,… Read More ›
Why Carbonxt Shares (ASX: CG1) Is A Stock To Buy
This article was originally published at MF & Co. Asset Management. Carbonxt (ASX CG1) specialises in providing oxidising, non-brominated activated carbons which are used to eliminate mercury by using carbon pellets to remove contaminants from a wide variety of gas… Read More ›
Top 5 Best Dividend Stocks To Buy Now On The ASX For 2019
This article was originally published at MF & Co. Asset Management. If you are entering a stage where you are looking for stocks that pay a strong, reliable and predictable dividend, the best place to look is for companies that… Read More ›
ParaZero (ASX:PRZ) – Blue Skies Ahead
Article written by Pitt Street Research. For the full report click here Safety systems for the fast growing drones market ParaZero Limited (ASX:PRZ) is an Israeli company that listed on the ASX in June 2018 to raise A$ 5M in capital… Read More ›
Why People Infrastructure Shares (ASX: PPE) Is A Stock To Buy
This article was originally published at MF & Co. Asset Management. People Infrastructure Ltd (ASX PPE), a workforce management company, provides contracted staffing and human resources outsourcing services in Australia and New Zealand. The company offers recruiting, on-boarding, rostering, timesheet… Read More ›
Sensera (ASX:SE1) – On track for operating cash flow breakeven by 4Q19
Article written by Pitt Street Research. For the full report click here Sensera Limited (ASX:SE1) designs, develops and manufactures Micro Devices (MEMS) for Medical and Industrial applications. Though recently acquired Nanotron, the company provides tracking solutions for the Agriculture, Mining and… Read More ›
Schrole Group (ASX: SCL) – Very strong start to the year for Advantage
Article written by Pitt Street Research. For the full report click here Schrole Group Limited (ASX: SCL) offers international schools a suite of technology- based candidate management solutions, including recruitment, background verification and relief placement. It also offers training service solutions… Read More ›
4DS Memory Ltd (ASX: 4DS) – Misunderstood and mispriced
Article written by Pitt Street Research. For the full report click here 4DS Memory (ASX:4DS) is a semiconductor development company aiming to provide an enterprise grade storage memory for cloud and data center storage markets. The company is developing a proprietary… Read More ›
Why PWR Holdings (ASX: PWH) Is A Stock To Buy
This article was originally published at MF & Co. Asset Management. PWR Holdings Limited (ASX PWH) is an Australia-based company which produces world-class cooling solutions for motorsports and automotive industry. Apart from providing high-performance radiators, intercoolers and oil coolers for… Read More ›
Centaur Resources (ASX: CR3) – Upcoming IPO – A Lithium Triangle play
Article written by Pitt Street Research. For the full report click here A Lithium Triangle play Centaur Resources is developing the Lobo Blanco Lithium Project in Argentina. This 100%-owned project, which covers around 11,000 ha of ground, is in an established… Read More ›
Linius Technologies (ASX: LNU) – Commercial roll-out is accelerating
Article written by Pitt Street Research. For the full report click here Linius Technologies Ltd. (ASX: LNU) provides a patented enterprise grade software technology that virtualizes video files and exposes the data within video content. This enables the manipulation and smart… Read More ›
G Medical Innovations Holdings (ASX:GMV) – Dual listing sought on Nasdaq
Article written by Pitt Street Research. For the full report click here NASDAQ listing would enable valuation comparison with true peers G Medical Innovations Holdings (ASX:GMV) is commercializing mobile vital signs monitoring systems that enable remote monitoring of patients. GMV’s products… Read More ›